{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:57:09Z","timestamp":1791489429600,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78833-1","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T06:52:39Z","timestamp":1731048759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exploring the mechanism of Suxin Hugan Fang in treating ulcerative colitis based on network pharmacology"],"prefix":"10.1038","volume":"14","author":[{"given":"Qiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Leong Xavier","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"issue":"1","key":"78833_CR1","first-page":"1","volume":"19","author":"S Ghosh","year":"2013","unstructured":"Ghosh, S. & Almadi, M. A. Inflammatory bowel disease: A Global Disease Saudi. J. Gastroenterol. 19 (1), 1\u20132 (2013).","journal-title":"J. Gastroenterol."},{"issue":"1","key":"78833_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41395-018-0233-2","volume":"114","author":"SC Ng","year":"2019","unstructured":"Ng, S. C. et al. Population Density and Risk of Inflammatory Bowel Disease: a prospective Population-based study in 13 countries or regions in Asia-Pacific. Am. J. Gastroenterol. 114 (1), 107\u2013115 (2019).","journal-title":"Am. J. Gastroenterol."},{"issue":"12","key":"78833_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","volume":"12","author":"GG Kaplan","year":"2015","unstructured":"Kaplan, G. G. The global burden of IBD: from 2015 to 2025. Nat. Reviews Gastroenterol. Hepatol. 12 (12), 720\u2013727 (2015).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"issue":"1","key":"78833_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ijc.28346","volume":"134","author":"U Nieminen","year":"2014","unstructured":"Nieminen, U. et al. Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data. Int. J. Cancer. 134 (1), 189\u2013196 (2014).","journal-title":"Int. J. Cancer"},{"key":"78833_CR5","doi-asserted-by":"crossref","unstructured":"Wang, W. et al. Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis. J. Ethnopharmacol., 277(114197). (2021).","DOI":"10.1016\/j.jep.2021.114197"},{"key":"78833_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7918261","volume-title":"Oxidative Stress and Effect of Treatment on the Oxidation Product Decomposition Processes in IBD","author":"E Dudzinska","year":"2018","unstructured":"Dudzinska, E. et al. Oxidative Stress and Effect of Treatment on the Oxidation Product Decomposition Processes in IBD (Oxidative Medicine and Cellular Longevity, 2018). 2018(7918261)."},{"key":"78833_CR7","doi-asserted-by":"crossref","unstructured":"Petkovic, M. et al. Dietary supplementation with sulforaphane ameliorates skin aging through activation of the Keap1-Nrf2 pathway. J. Nutr. Biochem., 98(108817). (2021).","DOI":"10.1016\/j.jnutbio.2021.108817"},{"issue":"8","key":"78833_CR8","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00204-015-1590-x","volume":"90","author":"C Huang","year":"2016","unstructured":"Huang, C. et al. Polymorphisms of human 8-oxoguanine DNA glycosylase 1 and 8-hydroxydeoxyguanosine increase susceptibility to arsenic methylation capacity-related urothelial carcinoma. Arch. Toxicol. 90 (8), 1917\u20131927 (2016).","journal-title":"Arch. Toxicol."},{"key":"78833_CR9","doi-asserted-by":"crossref","unstructured":"Lopez, A. & Peyrin-Biroulet, L. 5-Aminosalicylic acid and chemoprevention: does it work? Digestive diseases, 31(2): pp. 248\u2013253. (2013).","DOI":"10.1159\/000353806"},{"issue":"1","key":"78833_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40262-018-0676-z","volume":"58","author":"SE Berends","year":"2019","unstructured":"Berends, S. E. et al. Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of Ulcerative Colitis. Clin. Pharmacokinet. 58 (1), 15\u201337 (2019).","journal-title":"Clin. Pharmacokinet."},{"issue":"5","key":"78833_CR11","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1053\/j.gastro.2020.01.007","volume":"158","author":"S Singh","year":"2020","unstructured":"Singh, S. et al. AGA Technical Review on the management of moderate to severe Ulcerative Colitis. Gastroenterology. 158 (5), 1465\u2013 (2020).","journal-title":"Gastroenterology"},{"issue":"3","key":"78833_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/MCG.0b013e31802f19af","volume":"42","author":"RK Cross","year":"2008","unstructured":"Cross, R. K., Lapshin, O. & Finkelstein, J. Patient subjective assessment of drug side effects in inflammatory bowel disease. J. Clin. Gastroenterol. 42 (3), 244\u2013251 (2008).","journal-title":"J. Clin. Gastroenterol."},{"issue":"9","key":"78833_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11894-020-00781-3","volume":"22","author":"MS Barnhill","year":"2020","unstructured":"Barnhill, M. S. et al. Hepatotoxicty of agents used in the management of inflammatory bowel disease: a 2020 Update. Curr. Gastroenterol. Rep. 22 (9), 47 (2020).","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"1","key":"78833_CR14","first-page":"84","volume":"17","author":"F Pallavicino","year":"2013","unstructured":"Pallavicino, F. et al. Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine. Eur. Rev. Med. Pharmacol. Sci. 17 (1), 84\u201387 (2013).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"D1","key":"78833_CR15","doi-asserted-by":"publisher","first-page":"D1197","DOI":"10.1093\/nar\/gkaa1063","volume":"49","author":"S Fang","year":"2021","unstructured":"Fang, S. et al. A high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res. 49 (D1), D1197\u2013D1206 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"78833_CR16","first-page":"1034","volume":"45","author":"Z Yuan","year":"2020","unstructured":"Yuan, Z. et al. [Method and application of proteomics in study of targets of traditional Chinese medicines]. Zhongguo Zhong Yao Za Zhi\u2009=\u2009Zhongguo zhongyao zazhi\u2009=\u2009China. J. Chin. materia Med. 45 (5), 1034\u20131038 (2020).","journal-title":"J. Chin. materia Med."},{"issue":"1","key":"78833_CR17","doi-asserted-by":"publisher","first-page":"e23742","DOI":"10.1016\/j.heliyon.2023.e23742","volume":"10","author":"J Lu","year":"2024","unstructured":"Lu, J. et al. Exploring the molecular mechanism of Yinao Fujian formula on ischemic stroke based on network pharmacology and experimental verification. Heliyon. 10 (1), e23742 (2024).","journal-title":"Heliyon"},{"key":"78833_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1646905","volume-title":"Applications of Network Pharmacology in Traditional Chinese Medicine Research","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z. et al. Applications of Network Pharmacology in Traditional Chinese Medicine Research (Evidence-Based Complementary and Alternative Medicine, 2020). 2020(1646905)."},{"key":"78833_CR19","doi-asserted-by":"crossref","unstructured":"Yang, L. et al. A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease. Phytomedicine 92(153709) (2021).","DOI":"10.1016\/j.phymed.2021.153709"},{"issue":"1","key":"78833_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. Kyoto Encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"78833_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41575-020-00399-w","volume":"18","author":"S Mehandru","year":"2021","unstructured":"Mehandru, S. & Colombel, J. The intestinal barrier, an arbitrator turned provocateur in IBD. Nat. Reviews Gastroenterol. Hepatol. 18 (2), 83\u201384 (2021).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"key":"78833_CR22","doi-asserted-by":"crossref","unstructured":"Hansson, G. C., Kornberg, R. D. & Kornberg^Editors, R. D. Mucins and the Microbiome, in Annual Review of Biochemistry, pp. 769\u2013793. (2020).","DOI":"10.1146\/annurev-biochem-011520-105053"},{"issue":"48","key":"78833_CR23","doi-asserted-by":"publisher","first-page":"20388","DOI":"10.1073\/pnas.0908698106","volume":"106","author":"SS Iyer","year":"2009","unstructured":"Iyer, S. S. et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 106 (48), 20388\u201320393 (2009).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"78833_CR24","doi-asserted-by":"crossref","unstructured":"Candelli, M. et al. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel diseases. Int. J. Mol. Sci., 22(624212). (2021).","DOI":"10.3390\/ijms22126242"},{"issue":"4","key":"78833_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.17219\/acem\/130356","volume":"30","author":"A Pawlowska-Kamieniak","year":"2021","unstructured":"Pawlowska-Kamieniak, A., Krawiec, P. & Pac-Kozuchowska, E. Interleukin 6: biological significance and role in inflammatory bowel diseases. Adv. Clin. Experimental Med. 30 (4), 465\u2013469 (2021).","journal-title":"Adv. Clin. Experimental Med."},{"key":"78833_CR26","doi-asserted-by":"crossref","unstructured":"Tian, T., Wang, Z. & Zhang, J. Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. Oxidative Med. Cell. Longev., (2017). 2017(4535194).","DOI":"10.1155\/2017\/4535194"},{"issue":"10","key":"78833_CR27","first-page":"2403","volume":"21","author":"C Pereira","year":"2015","unstructured":"Pereira, C. et al. Oxidative stress and DNA damage: implications in inflammatory bowel disease. Inflamm. Bowel Dis. 21 (10), 2403\u20132417 (2015).","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"78833_CR28","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1007\/s10620-020-06427-8","volume":"66","author":"B Balram","year":"2021","unstructured":"Balram, B. et al. Poor drug sustainability in inflammatory bowel disease patients in clinical remission on Thiopurine Monotherapy. Dig. Dis. Sci. 66 (5), 1650\u20131657 (2021).","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"78833_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ibd.21349","volume":"17","author":"EI Benchimol","year":"2011","unstructured":"Benchimol, E. I. et al. Epidemiology of Pediatric Inflammatory Bowel Disease: a systematic review of International Trends. Inflamm. Bowel Dis. 17 (1), 423\u2013439 (2011).","journal-title":"Inflamm. Bowel Dis."},{"issue":"10256","key":"78833_CR30","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1016\/S0140-6736(20)32028-6","volume":"396","author":"SC Ng","year":"2020","unstructured":"Ng, S. C., Shi, H. Y. & Hamidi, N. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies (390, Pg 2769, 2018). Lancet. 396 (10256), E56\u2013E56 (2020).","journal-title":"Lancet"},{"key":"78833_CR31","doi-asserted-by":"crossref","unstructured":"Ferro, J. M. & Santos, M. O. Neurology of inflammatory bowel disease. J. Neurol. Sci., 424(117426). (2021).","DOI":"10.1016\/j.jns.2021.117426"},{"issue":"2","key":"78833_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cgh.2022.01.039","volume":"21","author":"JC Rodriguez-Duque","year":"2023","unstructured":"Rodriguez-Duque, J. C. et al. Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic metabolic risk factors. Clin. Gastroenterol. Hepatol. 21 (2), 406\u2013 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"78833_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00281-012-0352-6","volume":"35","author":"SI Grivennikov","year":"2013","unstructured":"Grivennikov, S. I. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin. Immunopathol. 35 (2), 229\u2013244 (2013).","journal-title":"Semin. Immunopathol."},{"issue":"3","key":"78833_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.23736\/S2724-5691.22.09369-8","volume":"77","author":"M Ortenzi","year":"2022","unstructured":"Ortenzi, M. et al. Complications after bowel resection for inflammatory bowel disease associated cancer: a systematic literature review. Minerva Surg. 77 (3), 272\u2013280 (2022).","journal-title":"Minerva Surg."},{"issue":"3","key":"78833_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/08916934.2013.873414","volume":"47","author":"AV Marzano","year":"2014","unstructured":"Marzano, A. V. et al. Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy. Autoimmunity. 47 (3), 146\u2013153 (2014).","journal-title":"Autoimmunity"},{"issue":"6","key":"78833_CR36","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.14309\/ajg.0000000000001220","volume":"116","author":"LE Targownik","year":"2021","unstructured":"Targownik, L. E. et al. Trends in Corticosteroid Use during the era of Biologic Therapy: a Population-based analysis. Am. J. Gastroenterol. 116 (6), 1284\u20131293 (2021).","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"78833_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.crohns.2013.01.009","volume":"7","author":"G Mocci","year":"2013","unstructured":"Mocci, G. et al. Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease. J. Crohns Colitis. 7 (10), 769\u2013779 (2013).","journal-title":"J. Crohns Colitis"},{"issue":"3","key":"78833_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11864-014-0288-2","volume":"15","author":"M Salaga","year":"2014","unstructured":"Salaga, M. et al. Chinese Herbal Medicines in the treatment of IBD and Colorectal Cancer: a review. Curr. Treat. Options Oncol. 15 (3), 405\u2013420 (2014).","journal-title":"Curr. Treat. Options Oncol."},{"key":"78833_CR39","doi-asserted-by":"crossref","unstructured":"Wu, F. et al. Wu-Mei-Wan ameliorates chronic colitis-associated intestinal fibrosis through inhibiting fibroblast activation. J. Ethnopharmacol., 252(112580). (2020).","DOI":"10.1016\/j.jep.2020.112580"},{"issue":"12","key":"78833_CR40","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41575-022-00658-y","volume":"19","author":"TE Adolph","year":"2022","unstructured":"Adolph, T. E. et al. The metabolic nature of inflammatory bowel diseases. Nat. Reviews Gastroenterol. Hepatol. 19 (12), 753\u2013767 (2022).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"key":"78833_CR41","doi-asserted-by":"crossref","unstructured":"Sartini, A. et al. Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease. Cell Death Dis., (2018). 9(87).","DOI":"10.1038\/s41419-017-0124-2"},{"issue":"9","key":"78833_CR42","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.autrev.2017.07.002","volume":"16","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases. Autoimmun. rev. 16 (9), 885\u2013896 (2017).","journal-title":"Autoimmun. rev."},{"issue":"11","key":"78833_CR43","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"D1","key":"78833_CR44","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51 (D1), D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"78833_CR45","doi-asserted-by":"crossref","unstructured":"Opdenakker, G., Vermeire, S. & Abu El-Asrar, A. How to place the duality of specific MMP-9 inhibition for treatment of inflammatory bowel diseases into clinical opportunities? Front. Immunol., 13(983964). (2022).","DOI":"10.3389\/fimmu.2022.983964"},{"issue":"1","key":"78833_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.smim.2013.12.003","volume":"26","author":"MJ Waldner","year":"2014","unstructured":"Waldner, M. J. & Neurath, M. F. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development. Semin. Immunol. 26 (1), 75\u201379 (2014).","journal-title":"Semin. Immunol."},{"key":"78833_CR47","doi-asserted-by":"crossref","unstructured":"Wang, Z. et al. Oxidative stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer. Oxidative Med. Cell. Longev., (2016). 2016(9875298).","DOI":"10.1155\/2016\/9875298"},{"key":"78833_CR48","doi-asserted-by":"crossref","unstructured":"Kasai, S. et al. Regulation of Nrf2 by mitochondrial reactive oxygen species in Physiology and Pathology. Biomolecules, 10(3202). (2020).","DOI":"10.3390\/biom10020320"},{"issue":"13","key":"78833_CR49","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1089\/neu.2016.4764","volume":"34","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Extracellular Signal-regulated Kinase\/Nuclear Factor-Erythroid2-like2\/Heme Oxygenase-1 pathway-mediated Mitophagy alleviates traumatic Brain Injury-Induced Intestinal Mucosa damage and epithelial barrier dysfunction. J. Neurotrauma. 34 (13), 2119\u20132131 (2017).","journal-title":"J. Neurotrauma"},{"key":"78833_CR50","doi-asserted-by":"publisher","first-page":"1337876","DOI":"10.3389\/fphar.2024.1337876","volume":"15","author":"Z Guo","year":"2024","unstructured":"Guo, Z. et al. Potential antidepressant effects of traditional Chinese botanical drug formula Chaihu-Shugan-San and its active ingredients. Front. Pharmacol. 15, 1337876\u20131337876 (2024).","journal-title":"Front. Pharmacol."},{"issue":"18","key":"78833_CR51","doi-asserted-by":"publisher","first-page":"9470","DOI":"10.1039\/D2FO00945E","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Prdx6-induced inhibition of ferroptosis in epithelial cells contributes to liquiritin-exerted alleviation of colitis. Food Funct. 13 (18), 9470\u20139480 (2022).","journal-title":"Food Funct."},{"key":"78833_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jff.2017.10.047","volume":"40","author":"M Lesjak","year":"2018","unstructured":"Lesjak, M. et al. Antioxidant and anti-inflammatory activities of quercetin and its derivatives. J. Funct. Foods. 40, 68\u201375 (2018).","journal-title":"J. Funct. Foods."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78833-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78833-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T07:06:25Z","timestamp":1731049585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78833-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78833"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78833-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27196"}}